Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FHP6X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,527
Award facts
- Contract value 100% obligated
- $87,526.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $87,526.72 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on October 21, 2025, with an ultimate completion date of October 22, 2025. The contract employs firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This award represents a child delivery order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This contract vehicle encompasses specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current delivery order for Dupixent—a biologic medication used to treat eczema, asthma, and other inflammatory conditions—exemplifies the company's role as a critical vendor for federal medical procurement needs within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26FHP6X?
SPE2DR26FHP6X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DR26FHP6X worth?
The government has obligated $87,527 on SPE2DR26FHP6X.
Is contract SPE2DR26FHP6X an order under another contract?
Yes. SPE2DR26FHP6X is a delivery order under SPE2DR25D1041, an indefinite delivery contract.
Was contract SPE2DR26FHP6X competed?
The extent of competition for SPE2DR26FHP6X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award